Severe Asthma in School-Age Children: Evaluation and Phenotypic Advances

Andrea Coverstone, Leonard B. Bacharier, Anne M. Fitzpatrick

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


Although the majority of children with asthma have a favorable clinical response to treatment with low to moderate doses of inhaled corticosteroids (ICS), a small subset of children have “severe” asthma characterized by ongoing symptoms and airway inflammation despite treatment with high doses of ICS and even oral corticosteroids. Although there is symptom heterogeneity in the affected children, children with severe asthma share the risk for adverse outcomes, including recurrent and potentially life-threatening exacerbations, which contribute to substantial economic burden. This article reviews current knowledge of severe asthma in school-age children (age 6–17 years) with a focus on recent literature published after January 2012. Clinical management approaches for children with severe asthma are discussed as well as current phenotyping efforts and emerging phenotypic-directed therapies that may be of benefit for subpopulations of children with severe asthma in the future.

Original languageEnglish
Article number20
JournalCurrent Allergy and Asthma Reports
Issue number5
StatePublished - May 3 2015


  • Asthma diagnosis
  • Asthma evaluation
  • Asthma phenotype
  • Asthma treatment
  • Children
  • Severe asthma


Dive into the research topics of 'Severe Asthma in School-Age Children: Evaluation and Phenotypic Advances'. Together they form a unique fingerprint.

Cite this